About 1,020,000 results
Open links in new tab
  1. U.S. Food and Drug Administration

    The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by …

  2. FDA en español | FDA

    La FDA es responsable de proteger la salud pública asegurando la seguridad, eficacia y protección de los medicamentos, los productos biológicos y los dispositivos médicos humanos …

  3. Recalls, Market Withdrawals, & Safety Alerts | FDA

    Recalls, Market Withdrawals, & Safety Alerts The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products.

  4. Drug Approvals and Databases | FDA

    Sep 24, 2025 · Novel Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products Drug and Biologic Approval and IND Activity Reports This Week's Drug …

  5. U S Food and Drug Administration Home Page

    April 12, 2019 - FDA approves first targeted therapy for metastatic bladder cancer

  6. FDA Newsroom | FDA

    Oct 2, 2024 · The latest news and events at the U.S. Food and Drug Administration (FDA) and resources for journalists.

  7. Novel Drug Approvals for 2025 | FDA

    Oct 24, 2025 · To see the FDA-approved conditions of use [e.g., indication (s), population (s), dosing regimen (s)] for each of these products, please see the most recently approved …

  8. Artificial Intelligence-Enabled Medical Devices | FDA

    Oct 7, 2025 · The FDA encourages the development of innovative, safe, and effective medical devices, including devices that incorporate artificial intelligence (AI).

  9. Orange Book: Approved Drug Products with Therapeutic …

    Please send general questions related to the drug data in these files to the Center for Drug Evaluation and Research, Division of Drug Information: [email protected].

  10. FDA Dashboards - Inspections

    FDA does not issue CGMP certificates at the conclusion of an inspection. Instead, this dashboard provides the outcomes, including classification and other details, of a firm’s most recent …